Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group - Kaufmann, M; Bajetta, E; Dirix, L Y (J Clin Oncol, 2000)